Inter Pharma Public Stock Fundamentals
| IP Stock | THB 3.54 0.04 1.12% |
Inter Pharma Public fundamentals help investors to digest information that contributes to Inter Pharma's financial success or failures. It also enables traders to predict the movement of Inter Stock. The fundamental analysis module provides a way to measure Inter Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inter Pharma stock.
Inter |
Inter Pharma Public Company Profit Margin Analysis
Inter Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Inter Pharma Profit Margin | 0.09 % |
Most of Inter Pharma's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inter Pharma Public is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Inter Pharma Public has a Profit Margin of 0.0946%. This is 100.84% lower than that of the Healthcare sector and 100.41% lower than that of the Biotechnology industry. The profit margin for all Thailand stocks is 107.45% lower than that of the firm.
Inter Pharma Public Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inter Pharma's current stock value. Our valuation model uses many indicators to compare Inter Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inter Pharma competition to find correlations between indicators driving Inter Pharma's intrinsic value. More Info.Inter Pharma Public is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Inter Pharma Public is roughly 1.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inter Pharma's earnings, one of the primary drivers of an investment's value.Inter Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inter Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inter Pharma could also be used in its relative valuation, which is a method of valuing Inter Pharma by comparing valuation metrics of similar companies.Inter Pharma is currently under evaluation in profit margin category among its peers.
Inter Fundamentals
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0524 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 4.5 B | |||
| Shares Outstanding | 372.52 M | |||
| Shares Owned By Insiders | 47.33 % | |||
| Shares Owned By Institutions | 2.72 % | |||
| Price To Earning | 115.05 X | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 3.66 X | |||
| Revenue | 908.63 M | |||
| Gross Profit | 413.14 M | |||
| EBITDA | 172.3 M | |||
| Net Income | 105.22 M | |||
| Cash And Equivalents | 153.09 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 187.06 M | |||
| Debt To Equity | 0.25 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 5.09 X | |||
| Cash Flow From Operations | (41.57 M) | |||
| Earnings Per Share | 0.43 X | |||
| Target Price | 20.0 | |||
| Beta | 0.5 | |||
| Market Capitalization | 5.59 B | |||
| Total Asset | 1.33 B | |||
| Z Score | 17.4 | |||
| Annual Yield | 0 % | |||
| Net Asset | 1.33 B |
About Inter Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inter Pharma Public's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inter Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inter Pharma Public based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.